Daishin Securities Bans Stock Trading by All Research Staff in Internal Control Overhaul

Reporter Paul Lee / approved : 2026-02-27 06:41:00
  • -
  • +
  • 인쇄

Photo courtesy of Yonhap News

 

[Alpha Biz= Paul Lee] Daishin Securities has imposed a blanket ban on stock trading by all employees in its research center, in a move widely seen as a significant tightening of internal controls.

According to the financial investment industry on the 26th, the brokerage recently implemented an internal policy prohibiting research staff from trading listed stocks under their personal names. The decision followed a prosecutors’ raid related to allegations that a former employee was involved in stock price manipulation.

Previously, trading restrictions for research personnel were limited to stocks they directly covered or analyzed, focusing on managing conflicts of interest and the misuse of non-public information. The new measure goes further by blocking virtually all stock trading by research staff, regardless of sector or coverage responsibility.

Market observers view the move as a preemptive effort to prevent reputational damage during an ongoing investigation and to reassure investors by strengthening controls over units with high access to market-sensitive information.

Daishin Securities has recently expanded internal audits and overhauled employee trading management standards, signaling a broader push to reinforce compliance and governance. The research center ban is seen as a symbolic step underscoring that shift.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

주요기사

Court Orders Provisional Seizure of Assets at Dawonsys Amid Dispute with Korail2026.02.27
Samchundang Pharm Signs Exclusive License and Commercialization Deal for Oral GLP-1 in 11 European Countries2026.02.27
Controversy Grows Over CEO Appointment at Korea Aerospace Industries2026.02.27
Meritz Financial Group Declines to Take Up KRW 480 Billion Senior Debt in IOTA Seoul Office Project2026.02.27
Former Samsung Biologics Employee Found Guilty of Trade Secret Misappropriation2026.02.27
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사